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Objectives. We examined the immediate and long-term out-
comes after stenting of unprotected left main coronary artery
(LMCA) stenoses in patients with normal left ventricular (LV)
function.
Background. Left main coronary artery disease is regarded as
an absolute contraindication for coronary angioplasty. Recently,
several reports on protected or unprotected LMCA stenting, or
both, suggested the possibility of percutaneous intervention for
this prohibited area.
Methods. Forty-two consecutive patients with unprotected
LMCA stenoses and normal LV function were treated with stents.
The post-stent antithrombotic regimens were aspirin and ticlopi-
dine; 14 patients also received warfarin. Patients were followed
very closely with monthly telephone interviews and follow-up
angiography at 6 months.
Results. The procedural success rate was 100%, with no epi-
sodes of subacute thrombosis regardless of anticoagulation regi-
men. Six-month follow-up angiography was performed in 32 of 34
eligible patients. Angiographic restenosis occurred in seven pa-
tients (22%, 95% confidence interval 7% to 37%); five patients
subsequently underwent elective coronary artery bypass graft
surgery (CABG), and two patients were treated with rotational
atherectomy plus adjunct balloon angioplasty. The only death
occurred 2 days after elective CABG for treatment of in-stent
restenosis. The other patients (without angiographic follow-up)
remain asymptomatic.
Conclusions. Stenting of unprotected LMCA stenoses may be a
safe and effective alternative to CABG in carefully selected
patients with normal LV function. Further studies in larger
patient populations are needed to assess late outcome.
(J Am Coll Cardiol 1998;31:37–42)
©1998 by the American College of Cardiology
Significant left main coronary artery (LMCA) disease is of
critical prognostic importance (1–3). Medical therapy of pa-
tients with LMCA disease is associated with a poor prognosis
(4,5). Initial studies of balloon angioplasty of unprotected
LMCA stenoses reported varying degrees of procedural suc-
cess (6–9), but uniformly poor long-term results (7–9). There-
fore, coronary artery bypass graft surgery (CABG) has been
the standard treatment for significant LMCA disease (10,11).
Stenting of unprotected LMCA stenoses has been at-
tempted as a therapeutic option in selected patients with
prohibitive surgical risk, usually as a result of noncardiac
comorbidities (12–14). A few cases of stenting of unprotected
LMCA stenoses have also been reported in bailout situations
(15–17). Thus far, elective stenting in patients with unpro-
tected LMCA stenoses has been regarded as a contraindica-
tion, mostly due to the potential fatal outcome from subacute
stent thrombosis. However, in the past few years there have
been significant improvements in both stent implantation
techniques (18) and post-stent antithrombotic regimens (19).
The objective of the current study was to determine
whether stenting of unprotected LMCA stenoses in selected
patients with normal left ventricular (LV) function is safe, and
thus may provide an alternative treatment to CABG.
Methods
Study patients. From November 1995 to February 1997, 42
consecutive patients with significant unprotected LMCA ste-
noses who declined CABG were treated with stent implanta-
tion. One patient had a limited life expectancy owing to
chronic myelogenous leukemia; the other 41 patients were
good surgical candidates but did not want to undergo CABG.
During the same period, 64 patients with significant LMCA
stenoses underwent CABG because of depressed LV function,
combined severe multiple stenosis of major epicardial arteries
or significant stenosis of the distal LMCA with involvement of
the proximal portion of the left anterior descending or left
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circumflex coronary artery. The inclusion criteria were 1)
clinical symptoms or objective evidence of myocardial ischemia
during an exercise test or thallium single-photon emission
computed tomographic imaging; and 2) angiographic evidence
of $50% diameter stenosis of the LMCA by quantitative
coronary angiographic (QCA) analysis. The criteria for exclu-
sion were 1) contraindication to aspirin or ticlopidine; and 2)
reduced LV function (ejection fraction #40%). In addition to
significant LMCA stenoses, significant narrowing of the right
coronary artery was observed in six patients. Stenting of the
right coronary artery was performed at the same time as
LMCA stenting in four patients.
All patients gave written, informed consent to participate in
the study. The study was carried out according to the principles
of the Declaration of Helsinki and was approved by our
Institutional Review Board on clinical study.
Stent implantation procedure. Stent implantation was per-
formed electively in 38 patients and in bailout situations in the
other four patients. An intraaortic balloon pump was prepared
for emergency cardiopulmonary support, if needed, but was
not inserted prophylactively. Predilation before stent implan-
tation was performed with undersized, conventional angio-
plasty balloons. The stents were then deployed by inflating the
stent delivery balloon at nominal pressure. After implantation
of the stent, the stented segment was further dilated with high
pressure balloon inflation to achieve angiographic optimiza-
tion. The balloon inflations were brief (,30 s) and multiple
($3) to avoid prolonged ischemia and ischemia-related com-
plications. No perfusion balloon catheters were used during
predilation, stent implantation or post-stent high pressure
dilation. The Palmaz-Schatz (Johnson & Johnson Interven-
tional Systems, Inc.), NIR (Medinol, Inc.) and Multi-Link
(Guidant, Inc.) tubular design stents were selected for lesions
at the ostium or shaft of the LMCA. The Gianturco-Roubin II
(Cook, Inc.), Microstent (Arterial Vascular Engineering, Inc.)
and Cordis (Cordis, Inc.) coil design stents were used for
lesions involving the distal bifurcation.
The size of stent was $3.5 mm in 88% of the lesions. The
lesions at the ostium or shaft without involvement of the distal
bifurcation comprised 79% of the lesions. The stents used to
treat LMCA stenoses were the Palmaz-Schatz stent in 25
patients, the NIR stent in 6 patients, the Cordis stent in 5
patients, the Multi-Link stent in 3 patients, the Gianturco-
Roubin II stent in 2 patients and the Microstent in 1 patient. A
debulking procedure before LMCA stenting was performed in
six patients (directional atherectomy in one patient and rota-
tional atherectomy in five patients).
During the procedure, patients received a 10,000-U bolus of
heparin with a repeat bolus of 5,000 U every 30 min to
maintain an activated clotting time .250 s. All patients were
kept in the coronary care unit for 24 h after stenting.
Anticoagulation/antiplatelet regimen. All patients received
aspirin and ticlopidine. Ticlopidine therapy (250 mg twice a
day) was started at least 3 days before the elective procedure
and continued for 1 month. All patients received aspirin
(200 mg/day). In the first 14 patients, anticoagulation therapy
using warfarin sodium was begun on the day of the procedure
and continued for 1 month. Heparin infusion was maintained
until the prothrombin time was in the therapeutic range
(International Normalized Ratio 2.0 to 3.0). In the last 28
patients, heparin infusion was discontinued 12 h after stent
implantation, and warfarin was not used.
Angiographic analysis. Two experienced angiographers
not involved in the stent procedure analyzed the angiographic
results. Percent diameter stenosis (DS), minimal lumen diam-
eter (MLD) and reference diameter using an on-line QCA
system (ANCOR version 2.0, Siemens) were measured before
predilation, after stenting plus adjunct balloon angioplasty and
at follow-up using a matched view showing the MLD. Angio-
graphic measurements were made during diastole after intra-
coronary nitroglycerin administration using the guiding cathe-
ter for magnification calibration. Single matched views with the
worst DS were compared. Angiographic restenosis was defined
as diameter stenosis $50% at follow-up.
Quantitative IVUS analysis. We tried to obtain intravas-
cular ultrasound (IVUS) images in every patient with stenting
of LMCA stenoses. The IVUS machine, however, was not
available at an early stage of the study. Intravascular ultra-
sound was not performed in patients with tight stenosis of the
LMCA because of hemodynamic compromise during the pas-
sage of the IVUS catheter across the lesions. Therefore, IVUS
was performed in 12 selected patients before predilation and
after stenting plus adjunct balloon angioplasty at a later stage
of the study. Intravascular ultrasound imaging was performed
after the administration of 0.2 mg of intracoronary nitroglyc-
erin. The IVUS system (Cardiovascular Imaging System, Inc.)
uses a 30-MHz transducer mounted on the end of a flexible
shaft that rotates at 1,800 rpm (within either a 2.9F long
monorail/common distal lumen imaging sheath or within a
3.2F short monorail imaging sheath) (20). Imaging was per-
formed using a motorized transducer pullback device, which
withdraws the transducer at a rate of 0.5 mm/s within the
stationary imaging sheath. Quantitative IVUS analysis was per-
formed using computer planimetry as previously described (20).
Clinical and angiographic follow-up. Clinical follow-up
was obtained by monthly telephone interviews. All patients
were requested to visit outpatient clinics at 1, 3 and 6 months
and to have follow-up angiograms at 6 months.
Statistical analysis. All data are expressed as the mean
value 6 SD.
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
DS 5 diameter stenosis
IVUS 5 intravascular ultrasound
LMCA 5 left main coronary artery
LV 5 left ventricular
MLD 5 minimal lumen diameter
QCA 5 quantitative coronary angiography
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Results
In-hospital outcome. The baseline clinical characteristics
of the 42 patients are shown in Table 1. The angiographic and
procedural characteristics of 42 lesions are shown in Table 2.
The procedural success rate was 100%. Figures 1 and 2 show
examples of successful stenting of the LMCA. Although an
intraaortic balloon pump was prepared for emergency cardio-
pulmonary support, no patients required this therapy. Major
in-hospital complications including stent thrombosis, myocar-
dial infarction, emergency CABG or death did not occur
regardless of stent type or anticoagulation therapy.
Results of QCA. The QCA measurements before predila-
tion, after stenting plus adjunct balloon angioplasty and at
follow-up are shown in Table 3. The mean reference vessel
diameter was 4.0 mm. The DS decreased from 73% before the
intervention to 25% after the intervention. The MLD in-
creased from 1.1 mm before the intervention to 4.2 mm after
the intervention. At follow-up, the DS was 26% and the MLD
was 2.8 mm.
Guidance of IVUS. Because of IVUS findings of incom-
plete stent expansion, four patients underwent additional
angioplasty with higher pressures or a larger sized balloon. In
one patient, despite angiographic optimization, IVUS detected
significant residual plaque burden at the ostium of the LMCA,
which was not covered by the stent; therefore, an additional
half-stent was implanted.
Late clinical outcomes and angiographic restenosis rate.
Clinical follow-up with monthly telephone interviews and
outpatient clinic visits revealed recurrence in 7 of 42 patients
(17%, 95% confidence interval [CI] 5 to 28). The mean
duration of clinical follow-up was 10.2 6 4.7 months (range 3
to 17) in patients without restenosis. Restenosis occurred
within 2 months (mean 1.8 6 0.3) after LMCA stenting. The
clinical manifestation was unstable angina in all patients with
restenosis. Myocardial infarction did not occur during
follow-up in all patients.
Angiographic follow-up data were obtained for 32 of the 34
eligible patients who underwent LMCA stenting. Two patients
who refused angiographic follow-up were asymptomatic.
Follow-up angiography for the remaining eight patients is
scheduled to be performed 6 months after the intervention.
Angiographic restenosis occurred in seven patients (22%,
95% CI 7 to 37). The distal bifurcation was involved in all
patients, including those whose initial lesion only involved the
ostium. Elective CABG was performed in five patients, and
rotational atherectomy plus adjunct balloon angioplasty was
performed in two patients. Among these patients, one death
(in a middle-aged woman with Takayasu’s arteritis) occurred 2
days after elective CABG.
Discussion
This clinical study shows that stenting of unprotected
LMCA stenoses may be as safe and effective in carefully
selected patients with normal LV function. The procedure was
successful in all patients, and there were no episodes of
subacute stent thrombosis. Despite the large final MLD,
restenosis occurred in 22% (95% CI 7 to 37) of patients
(uniformly involving the distal LMCA). However, there were
no incidences of sudden death or nonfatal myocardial infarc-
tion during the follow-up period.
Previous studies with balloon angioplasty and advantages
of stents. Balloon angioplasty of unprotected LMCA stenoses
has been associated with varying degrees of procedural success,
but generally poor long-term prognosis (6–9). Previously re-
ported unprotected LMCA stent procedures have been done in
conditions of prohibitive surgical risk or in bailout situations
(12–17). Other investigators have reported primarily protected
LMCA stenting (21–23).
The current study indicates that stenting of LMCA stenoses
improves both the immediate procedural success and the
long-term clinical outcomes compared with balloon angio-
plasty, in part because of the low subacute stent thrombosis
Table 1. Baseline Clinical Characteristics of 42 Study Patients
Age (yr) 54.3 6 7.1
Male gender 62%
Cardiac risk factors
Hypertension 38%
Diabetes mellitus 29%
Hypercholesterolemia 12%
Current smoker 41%
Myocardial infarction
Previous 5%
Acute 2%
Unstable angina 69%
No. of diseased coronary arteries
LMCA only 86%
LMCA and RCA 14%
LVEF (%) 56 6 12
Data presented are mean value 6 SD or percent of patients. LMCA 5 left
main coronary artery; LVEF 5 left ventricular ejection fraction; RCA 5 right
coronary artery.
Table 2. Angiographic and Procedural Characteristics of 42 Lesions
Lesion location
Aorto-ostial 45%
Confined to shaft 33%
Involving distal bifurcation 21%
Final diameter of stent
3.0–3.5 mm 12%
3.5–4.0 mm 50%
$4.0 mm 38%
Type of stent
Palmaz-Schatz 60%
NIR 14%
Cordis 12%
Multi-Link 7%
Gianturco-Roubin II 5%
Microstent 2%
Multiple stents 5%
Procedural success 100%
Data presented are percent of lesions.
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rate using optimal stent implantation techniques (18) and new
antiplatelet agents (19). Most of the procedures in the current
study were elective; all patients had normal LV function; and
balloon inflations were intentionally kept short in duration.
These facts may explain the high procedural success rate.
Regardless of anticoagulation therapy, major in-hospital com-
plications did not occur in the current study. This finding
suggests that antiplatelet therapy alone might be an effective
post-stent antithrombotic regimen even in the LMCA.
Lesion-specific stent selection. The high concentration of
elastic fibers in the aorto-ostial and proximal segments of the
LMCA has been proposed as the possible mechanism of elastic
recoil and high restenosis rate of conventional coronary angio-
plasty at these sites (7). For this reason, the slotted-tube stent,
instead of the coil stent, was considered to be the stent of
choice in case of ostial lesions of the LMCA. In contrast, for
distal bifurcating lesions, coiled stents were used. For example,
in one example of an angled lesion in the distal LMCA and
proximal portion of the left circumflex artery, a coiled stent
was placed from the LMCA into the left circumflex artery, and
then another slotted-tube stent was placed in the proximal
portion of left anterior descending coronary artery through the
struts of coil stent (Fig. 2).
Rotational atherectomy before LMCA stenting was per-
formed in five patients. The beneficial effects of the debulking
procedure before LMCA stenting needs to be evaluated in
larger numbers of patients. However, preliminary data support
the concept of debulking before stenting (24,25).
Guidance of IVUS. Intravascular ultrasound may be an
especially important adjunctive imaging modality for LMCA
intervention. Despite its clinical significance, LMCA disease is
often neither accurately nor precisely evaluated by coronary
angiography (26,27). Unlike angiography, IVUS provides to-
mographic images that delineate the composition and topog-
raphy of normal and atherosclerotic vascular structures.
In the current study, in one patient, despite angiographic
optimization, IVUS revealed significant residual plaque bur-
den at the ostium of the LMCA not covered by the stent. In
general, IVUS had a critical role in our decision to implant
additional stents in ostial lesions. There was a marked
discrepancy between QCA analysis and IVUS findings.
Based on these data, IVUS guidance may improve decisions
Figure 1. A, Left coronary angiogram showing a tight stenosis of the
ostium of the LMCA (arrow). B, No residual stenosis after stenting. C,
Left coronary angiogram showing a tight stenosis of the shaft of the
LMCA (arrow). D, No residual stenosis after stenting.
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regarding the size, length and type of stents and additional
procedures.
Late clinical outcomes and angiographic restenosis rate.
In the current study, meticulous clinical follow-up with
monthly telephone interviews and outpatient clinic visits re-
vealed clinical recurrence in 7 of 42 patients (17%, 95% CI 5
to 28). The restenosis occurred early (within 2 months) after
LMCA stenting. The clinical manifestation was usually unsta-
ble angina. Therefore, we followed our patients carefully by
telephone interview each month. High restenosis rates
($50%) and adverse clinical events have been reported during
follow-up in previous studies of balloon angioplasty or laser
angioplasty of LMCA stenoses (7,28). However, other previous
studies of stenting of LMCA stenoses (albeit in small numbers
of patients) showed acceptable angiographic restenosis rates
and clinical events during follow-up (21–23). In the current study,
the angiographic restenosis rate (22%, 95% CI 7 to 37) was
similar to that of the previous studies (21–23). Compared with
restenosis rates after balloon angioplasty or laser angioplasty, low
restenosis rates after stenting of LMCA stenoses may be attrib-
uted to larger post-stent lumen dimensions and to the effect of
stents in resisting pathologic arterial remodeling and acute recoil.
Of the 32 patients who had angiographic follow-up, 24 had
stent implantation at the ostial or proximal portion of the
LMCA. Angiographic restenosis occurred in 4 of 24 patients in
this subgroup. In all patients with restenosis of the LMCA in
the current study, the site of restenosis involved the distal
bifurcation. This may be explained in part by incomplete stent
coverage of significant lesions at the distal LMCA or proximal
left anterior descending coronary artery not be detected by
angiography. Because the length of the entire LMCA can be
less than the balloon length, injury during high pressure
balloon inflation might occur in both the distal LMCA and
proximal segment of the branch vessel (e.g., left anterior
descending coronary artery).
There were some limitations in the current study. First,
IVUS images were obtained in only 12 patients at a later stage
Figure 2. A, Left coronary angiogram showing narrowing of the distal
part of LMCA with a tight stenosis of the ostium of left anterior
descending coronary artery with severe calcification (arrow). B, Rota-
tional atherectomy of the proximal left anterior descending coronary
artery. C, Compromise of the ostium of left circumflex coronary artery
after rotablation of the left anterior descending coronary artery
(arrow). D, Cordis stent implantation from the LMCA to the proximal
left circumflex coronary artery. E and F, Palmaz-Schatz stent implan-
tation (arrow) at the ostium of the left anterior descending coronary
artery through the struts of the Cordis coil stent. G, Left coronary
angiogram 6 months later revealing a patent LMCA, proximal left
anterior descending coronary artery and proximal left circumflex
coronary artery.
Table 3. Results of Quantitative Angiographic Analysis
Reference vessel diameter (mm) 4.0 6 0.5
Balloon to artery ratio 1.06 6 0.04
Diameter stenosis (%)
Baseline 73 6 9
Final 25 6 4
Follow-up 26 6 21
Minimal lumen diameter (mm)
Baseline 1.1 6 0.3
Final 4.2 6 0.5
Follow-up 2.8 6 0.9
Acute gain (mm) 3.1 6 0.2
Late loss (mm) 1.4 6 0.6
Maximal balloon inflation pressure (atm) 15.7 6 1.9
Data presented are mean value 6 SD.
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of the study. Second, angiographic follow-up data were not
obtained in all study groups. However, the angiographic
follow-up rate was 94% (32 of 34 eligible patients). Follow-up
angiography for the remaining patients is scheduled to be
performed 6 months after the intervention.
Conclusions and clinical implications. Patients most suit-
able for unprotected LMCA stenting may be those with
isolated LMCA disease and normal LV function. The most
suitable lesions are those limited to the LMCA shaft, especially
the ostium or proximal portion of the LMCA, or both. Inflating
the balloons in the distal LMCA might be avoided, if possible.
If the lesions involve the bifurcation area, a maximal debulking
procedure or stenting, or both, of the proximal portion of the
left anterior descending coronary artery and left circumflex
artery might be considered to reduce restenosis. Further
clinical study with larger numbers of patients will be needed to
evaluate the late outcomes after stenting of LMCA stenoses.
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